Additionally, at all LUAD tumor stage-to-stage interfaces, there was an overwhelming amount of consensus between genes in the AK4 gene signatures that—via sPLS-DA—predicted LUAD tumor advancement and the survival analysis. The gene discussed is AK4; the disease is neoplasm.